Day August 30, 2016

FDA approves Erelzi, a biosimilar to Enbrel

The U.S. Food and Drug Administration today approved Erelzi, (etanercept-szzs) for multiple inflammatory diseases. Erelzi is a biosimilar to Enbrel (etanercept), which was originally licensed in 1998. Erelzi is administered by injection for the treatment of: moderate to severe rheumatoid…

Novel technology LifeVest can help newborns breathe

LifeVest, a technology being developed at St. Michael’s Hospital to help newborns breathe, won the Global Healthcare Innovation Academy’s international competition in Calgary. Global Healthcare Innovation Academy brought together innovators, entrepreneurs, investors, and industry for its scientific and business innovation…